Table 2. All attributes in PMI5 groups (PMI:non-PMI =1:1 from 10,886).
| Categories | Variables | Drop | Mean | |||||
|---|---|---|---|---|---|---|---|---|
| PMI group (N=1,494) | Non-PMI group (N=1,494) | P | PMI group (N=1,494) | Non-PMI group (N=1,494) | P | |||
| General information | Gender, male% | 67% | 68% | 0.532 | 69% | 73% | 0.089 | |
| Age, years | 64.38±18.53 | 63.51±20.44 | 0.223 | 67.8±10.21 | 68.14±9.84 | 0.355 | ||
| BMI, kg/m2 | 23.29±6.18 | 23.88±6.78 | <0.05 | 24.41±3.4 | 24.74±4.96 | <0.05 | ||
| SYB, mmHg | 133.83±23.42 | 132.37±22.28 | 0.082 | 134.71±20.68 | 133.35±19.14 | 0.061 | ||
| DBP, mmHg | 73.52±25.08 | 73.57±21.03 | 0.946 | 74.15±24.12 | 74.16±19.96 | 0.992 | ||
| Medical history | UAP, yes | 40% | 44% | 0.167 | 40% | 44% | <0.05 | |
| Hyper, yes | 71% | 66% | <0.05 | 73% | 70% | <0.05 | ||
| DM, yes | 27% | 26% | 0.619 | 27% | 26% | 0.890 | ||
| P-CVD, yes | 23% | 21% | 0.058 | 23% | 21% | 0.058 | ||
| P-PCI, yes | 25% | 39% | <0.05 | 25% | 39% | <0.05 | ||
| Smoking, yes | 38% | 41% | 0.108 | 38% | 41% | 0.096 | ||
| Drinking, yes | 24% | 28% | <0.05 | 24% | 28% | <0.05 | ||
| F-CVD, yes | 13% | 12% | 0.349 | 13% | 12% | 0.349 | ||
| Biochemistry results | TC, mmol/L | 3.77±1.27 | 3.86±1.33 | 0.058 | 3.88±1.09 | 4.0±1.11 | <0.05 | |
| HDL-C, mmol/L | 0.98±0.31 | 1.03±0.35 | <0.05 | 1.01±0.26 | 1.06±0.29 | <0.05 | ||
| LDL-C, mmol/L | 1.96±0.9 | 1.92±0.92 | 0.278 | 2.02±0.84 | 2.0±0.84 | 0.540 | ||
| VLDL-C, mmol/L | 0.89±1.34 | 0.91±1.1 | 0.669 | 0.92±1.33 | 0.95±1.09 | 0.553 | ||
| TG, mmol/L | 1.54±1.04 | 1.58±1.11 | 0.369 | 1.59±1.01 | 1.64±1.07 | 0.226 | ||
| LPa, mg/dL | 25.72±27.22 | 22.13±24.04 | <0.05 | 26.47±26.83 | 23.07±23.63 | <0.05 | ||
| TB, µmol/L | 12.67±6.46 | 13.04±6.97 | 0.133 | 12.91±6.22 | 13.42±6.58 | <0.05 | ||
| UB, µmol/L | 8.93±4.93 | 9.13±4.8 | 0.258 | 9.11±4.76 | 9.42±4.51 | 0.071 | ||
| CB, µmol/L | 3.74±2.12 | 3.9±3.23 | 0.112 | 3.81±2.05 | 4.01±3.15 | <0.05 | ||
| UA, µmol/L | 347.92±120.14 | 344.7±115.29 | 0.454 | 361.84±96.84 | 359.31±89.83 | 0.459 | ||
| Cr, µmol/L | 82.37±44.16 | 84.08±55.49 | 0.35 | 82.42±44.11 | 84.08±55.49 | 0.365 | ||
| BUN, mmol/L | 5.44±2.28 | 5.28±1.98 | <0.05 | 5.45±2.27 | 5.28±1.98 | <0.05 | ||
| eGFR, mL/min | 76.57±25.34 | 75.15±25.72 | 0.128 | 80.31±18.81 | 80.01±17.19 | 0.646 | ||
| Blood routine examinations | WBC, ×109 | 6.63±2.07 | 6.43±1.7 | <0.05 | 6.63±2.07 | 6.43±1.69 | <0.05 | |
| Lymphocyte, % | 24.34±7.79 | 25.59±8.07 | <0.05 | 24.34±7.79 | 25.59±8.07 | <0.05 | ||
| Neutrophil, % | 64.37±9.95 | 62.53±10.93 | <0.05 | 64.37±9.95 | 62.53±10.93 | <0.05 | ||
| Plt, ×109 | 176.13±57.28 | 174.03±53.12 | 0.300 | 176.72±56.36 | 174.5±52.35 | 0.266 | ||
| MPV, fL | 9.17±1.41 | 8.99±1.43 | <0.05 | 9.17±1.41 | 9.01±1.37 | <0.05 | ||
| CRP, mg/L | 4.36±10.5 | 3.06±8.99 | <0.05 | 5.01±11.93 | 4.22±9.21 | <0.05 | ||
| CKMB, IU | 18.25±14.47 | 13.87±8.35 | <0.05 | 18.25±14.47 | 13.87±8.35 | <0.05 | ||
| FBG, mg/L | 6.67±2.59 | 6.55±2.43 | 0.178 | 6.68±2.58 | 6.55±2.43 | 0.163 | ||
| Medicine | Anti-Hyper Med, yes | 86% | 84% | 0.169 | 86% | 84% | 0.169 | |
| Statins, yes | 98% | 98% | 0.449 | 98% | 98% | 0.374 | ||
| Anti-Plt Med, yes | 100% | 100% | 0.076 | 0.076 | ||||
| Trimetazidine, yes | 25% | 22% | 0.064 | 25% | 22% | 0.062 | ||
| Fibrates, yes | 0% | 0% | 0.781 | 0% | 0% | 0.782 | ||
| Cilostazol, yes | 2% | 2% | 0.229 | 2% | 2% | 0.228 | ||
| Warfarin, yes | 1% | 1% | 1.000 | 1% | 1% | 0.999 | ||
| PPI, yes | 51% | 38% | <0.05 | 51% | 38% | <0.05 | ||
| Ezetimibe, yes | 8% | 6% | 0.051 | 8% | 6% | 0.050 | ||
| Procedure factors | FFR, IVUS, OCT, yes | 14% | 10% | <0.05 | 14% | 10% | <0.05 | |
| CTO, yes | 12% | 5% | <0.05 | 12% | 5% | <0.05 | ||
| ACC/AHA TypeB2C, yes | 39% | 23% | <0.05 | 39% | 23% | <0.05 | ||
| Left coronary artery, yes | 26% | 31% | <0.05 | 26% | 31% | <0.05 | ||
| Total length of stents, mm | 51.47±25.37 | 33.34±20.23 | <0.05 | 51.47±25.37 | 33.34±20.23 | <0.05 | ||
| Number of stents, N | 1.75±0.85 | 1.37±0.662 | <0.05 | 1.75±0.85 | 1.37±0.662 | <0.05 | ||
| Diameter of stent ≥2.5 mm | 91 | 92 | 0.146 | 91 | 92 | 0.146 | ||
| Calcification, yes | 17% | 8% | <0.05 | 17% | 8% | <0.05 | ||
| PCI without dilation, yes | 11% | 11% | 0.772 | 11% | 11% | 0.772 | ||
P value: t-statistic testing between negative group and positive group, <0.05 means significant statistically. BMI, body mass index; SYB, systolic blood pressure; DBP, diastolic blood pressure; UAP, unstable angina pectoris; Hyper, hypertension; DM, diabetes mellitus; P-CVD, past history of cerebral-or-cardiovascular diseases; P-PCI, past history of percutaneous coronary intervention; F-CVD, family history of cerebral-or-cardiovascular diseases; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipid cholesterol; VLDL-C, very low density lipid cholesterol; TG, triglyceride; LPa, lipid protein alpha; TB, total bilirubin; UB, unconjugated bilirubin; CB, conjugated bilirubin; UA, uric acid; Cr, creatinine; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; WBC, white blood cells; Plt, platelet; MPV, mean platelet volume; CRP, C-reactive protein; CKMB, Creatine Kinase MB; FBG, fibrinogen; anti-Hyper Med, anti-hypertension medicine; anti-Plt Med, anti-platelet medicine; PPI, proton-pump inhibitors; FFR, fractional flow reserve; IVUS, intravascular ultrasound; OCT, optical coherence tomography; CTO, chronic total occlusions.